# Acologix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acologix

- Industry: Biotechnology
- Headquarters: Hayward, US
- Website: www.acologix.com
- Total disclosed funding: $65M
- Latest round: Series C (Dec 20, 2005)
- Investors on record: 6

## About

Acologix Inc. is a healthcare technology company focused on enhancing patient engagement through innovative telehealth platforms and integrated health management systems, facilitating efficient healthcare delivery.Founded in 1992 and headquartered in Hayward, US, Acologix Inc. specializes in developing healthcare solutions. The company has undergone various strategic pivots to enhance its offerings. It has received a total of USD 4.5 mn in funding, culminating in the most recent Series C round on February 14, 2006. This funding has supported their growth strategy, targeting advancements in healthcare technology and client services in North America and Europe.Acologix specializes in the development and provision of innovative solutions that cater to the evolving needs of the healthcare sector. Their core offerings include advanced telehealth platforms and integrated health management systems designed to enhance patient engagement and streamline healthcare delivery. These products facilitate remote consultations, patient monitoring, and data analytics, allowing healthcare providers to deliver efficient and effective care. Acologix primarily serves hospitals, clinics, and healthcare networks across North America and Europe, focusing on enhancing patient outcomes and operational efficiencies. Additionally, they target technology-savvy consumers who seek accessible healthcare solutions, ensuring comprehensive service across diverse geographical markets.Acologix generates revenue through a combination of subscription-based models and direct service agreements with healthcare institutions. Clients typically enter into annual contracts for access to Acologix's telehealth solutions, providing predictable and recurring revenue streams for the company. The pricing structure is designed to cater to various organizational sizes, with tiered subscription plans that accommodate both small practices and large healthcare systems. Flagship offerings include their proprietary telehealth platform, which enables seamless remote consultations, as well as health management tools that enhance operational workflows. This transaction structure supports a robust B2B model, fostering long-term partnerships with healthcare providers aiming to innovate and improve service delivery.Acologix plans to leverage its Series C funding of USD 4.5 mn to enhance its product offerings and expand into new markets. They are currently designing innovative telehealth solutions slated for release by late 2023, aiming to improve healthcare accessibility in underserved areas. Additionally, the company is focused on expanding its presence in the European market, with targeted efforts to establish partnerships with local healthcare networks by 2024, which aligns with their strategy of enhancing patient care through technology.

## Funding rounds

- Series C, Dec 20, 2005, $25M — Nomura Securities, Jaic America Inc., Tokio Marine & Nichido Fire Insurance Co., Nomura Research and Advisory
- Series B, May 3, 2004, $40M — SBI Holdings, Daiwa Corporate Investment, Nomura Securities, Jaic America Inc., Tokio Marine & Nichido Fire Insurance Co., Nomura Research and Advisory

## Investors

- SBI Holdings — Series B
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series B
- Nomura Securities — Series B, Series C
- Jaic America Inc. (https://capitalatlas.ai/funds/jaic-america-inc) — Series B, Series C
- Tokio Marine & Nichido Fire Insurance Co. — Series B, Series C
- Nomura Research and Advisory (https://capitalatlas.ai/funds/nomura-research-and-advisory) — Series B, Series C